U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

CLEOME RUBELLA WHOLE

MORE DETAILS

ENF501RK2Z

structurally diverse
Status:
Other
Class:
STRUCTURALLY DIVERSE

ADINA RUBELLA WHOLE

MORE DETAILS

1S210XS3BZ

structurally diverse
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2016)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fbfc4ac-75a5-6e28-e054-00144ff8d46c
First approved in 2016
Source:
21 CFR 348
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fbfc4ac-75a5-6e28-e054-00144ff8d46c
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966